2014 AVDA Annual Conference — Scottsdale, Arizona
Registration is open for April 27-29, 2014! The 2014 AVDA Annual Conference will be held at the end of April at the beautiful Fairmont Scottsdale Princess in Scottsdale, Arizona. The Fairmont Scottsdale Princess is a AAA - Five Diamond property located in the Valley of the Sun, just minutes away from shopping and just a short drive from Sedona and the Grand Canyon.

AVDA has once again secured economist Alan Beaulieu to present to the group on Monday morning, April 28th. In addition to Alan, speakers include Dennis Snow, Herb Meyer, and Matt Birk. Special thanks to our Platinum Sponsors for sponsoring our speakers. They are Merial, Novartis Animal Heath, Bayer Animal Health, and Nestle Purina PetCare. Click here to view the full schedule and promotional brochure.

The AVDA discounted group rate is $279 per night. Fairmont Scottsdale Princess is located approximately 30 miles from the Phoenix Sky Harbor International Airport. Average temperature in April is high of 77 degrees, low of 50. Click here to book your hotel room online. Click here for more information.

AVDA Welcomes New Associate Board Member
The AVDA Board recently announced changes to the association bylaws. One of the changes was to increase the number of Associate members serving on the board from 2 to 3. Associate Member Directors are now appointed by the Active members of the Board. Their terms will be three years and the terms of the initial Associate directors members may be staggered so that one new member would be appointed each year. These members can be reappointed to additional terms. The newest Associate Member Director to be appointed to a three year term is Renee Hall of Merial. She joins Chuck Barrier of Boehringer Ingelheim Vetmedica and Robin Mease of Merck Animal Health. Click here to read more.

AVDA recently submitted public comments in regards to the DEA's Federal Register notice of proposed rulemaking: Schedules of Controlled Substances: Placement of Tramadol Into Schedule IV.
AVDA supports DEA's proposed rule designating Tramadol as a scheduled IV controlled substance because this action will enable distributors to operate with efficiency and consistency across the states along with requiring an increased level of due diligence and monitoring. Tramad l is an important drug in veterinary medicine and is supplied to veterinarians and animal health clinics by our distributor members. Tramadol is administered to dogs, cats and many non-domestic animals as an analgesic and as a pain reliever after surgical procedures. Click here to read the full document.

Legal Update: FTC Enforcement Actions Continue
At the September, 2013 Board meeting I advised you of recent activity of the Federal Trade Commission pertaining to the exchange of sensitive business information by and between competitors (Federal Trade Commission v. Bosley, No. 121-0184). While the information exchange was clearly inadvisable, the Commission's position was not based upon any allegations of harm to competition. Rather, the Commission used its authority under Section 5 of the FTC Act to find the Respondent violated the Act solely by exchanging the information and presuming such an exchange could lead to an adverse impact on competition.

The FTC continues to scrutinize the activities of competitors and trade associations. The Commission recently published proposed consent orders in two cases involving trade associations which are discussed below. Click here to read the full update.